Nevasic 2.5

The Nevasic program is effective for a wide range of conditions including pregnancy sickness, travel sickness, and sickness related to medical conditions and prescribed drugs.

Nevasic is a medical audio program that stabilizes the balance receptors in the inner ear to provide relief from nausea and sickness. It delivers precisely engineered stabilizing audio pulses and frequencies embedded in music for ease of use.

• Clinical trial - Motion sickness
• The MRC Spatial Disorientation Group at Imperial College School of Medicine in London conducted a clinical trial under the brand name TravelWell. The trial conclusively proved the effectiveness of the program in combating symptoms of motion sickness. The report is available through PubMed at the National Library of Medicine (USA).
• NHS study - Morning sickness
• Nevasic was studied by the UK NHS under the brand name MorningWell. The study showed that 9 out of 10 pregnant women experienced a reduction or elimination of morning sickness symptoms by using Nevasic.
• Clinical Trial - Cancer patients
• Manchester University conducted a clinical trial on mastectomy patients with encouraging results, leading to a nationwide clinical trial request by UK research institutes.
• Nevasic is a registered Class 1 Medical Device in the UK, USA, and Australia, exempt from the Therapeutic Goods Act.

Reviews:

• A testimonial from a US customer expressed satisfaction with the program's effectiveness in alleviating sickness symptoms, sharing a personal experience of relief and recommending Nevasic to others. The customer highlighted the impact on their daily life and expressed gratitude for finding the program.